Aims and scope
Thorax is one of the world’s leading respiratory medicine journals, publishing clinical and experimental research articles on respiratory medicine, critical care, paediatrics, immunology, pharmacology, pathology, and surgery. Thorax seeks to publish significant advances in scientific understanding, which are likely to impact on clinical practice. This includes articles concerning basic and translational mechanisms with application to clinical material (cell and molecular biology, genetics, epidemiology, and immunology).
|Publication Model||Subscription; with hybrid open access option|
|Indexed by||Web of Science Core Collection: Science Citation Index, Science Citation Index Extended; BIOSIS Reviews, Current Contents: Clinical Medicine, Life Sciences; MEDLINE (Index Medicus), PubMed Central, Scopus, Embase (Excerpta Medica), CINAHL, Google Scholar|
|Impact Factor||9.640 (JCR 2018)|
|Peer Review Model||Single blind; the names of reviewers are hidden from the author|
Journal statistics (2018)
|Acceptance Rate||9% for original research|
|Instant Rejection Rate||72%|
|Time from Submission to First Decision||13 days|
|Time from Acceptance to Publication||21 days|
Rights and permissions
BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. The BMJ Group is a sponsor of its activities.